Off the shelf cell therapies – what could go wrong?

This was a while back but I cannot help bringing it up again as cryopreservation is basic to the development of cell therapies – the future for unmet medical need: "What is lost or gained with cryopreservation that could give an advantage/disadvantage to minimally manipulated cells (and an argument for regulation of SCs as drugs)?" Two things came to mind …